| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |